|
Index of reports
> Serious Reactions (887)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 887 Next >>
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Pancreatitis Acute, Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-15
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-20
Telaprevir
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-11
End date: 2012-06-20
Other drugs received by patient: Talion (Bepotastine Besylate); Feburic; Famostagine D; NEO-Minophagen C; Urdeston; Trebianom; Sitagliptin Phosphate
Possible PEG-Intron side effects in
Reported by a individual with unspecified qualification from Germany on 2012-08-27
Patient:
Reactions: Maternal Exposure Before Pregnancy, Abortion Induced
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk
Indication: Hepatitis
End date: 2012-01-01
Rebetol
Dosage: unk
End date: 2012-01-01
Victrelis
Dosage: 200 mg, qd
Indication: Hepatitis
Start date: 2012-01-09
End date: 2012-05-01
Other drugs received by patient: Lexotanil
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Generalised Erythema
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, unk
Indication: Hepatitis C
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Start date: 2012-05-08
End date: 2012-05-14
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-05-15
Rebetol
Dosage: 1000 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-05-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-03
End date: 2012-07-05
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-24
End date: 2012-06-11
Other drugs received by patient: Norvasc; Rinderon V; Allopurinol; Hirudoid; Xyzal; Allopurinol; Prednisolone; Rabeprazole Sodium; Rabeprazole Sodium; [composition Unspecified]; Clobetasol Propionate; Sitagliptin Phosphate
Possible PEG-Intron side effects in
Reported by a physician from United States on 2012-08-27
Patient:
Reactions: Exposure VIA Father
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Platelet Count Decreased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram, qw
Start date: 2012-05-02
End date: 2012-05-02
PEG-Intron
Dosage: 40 microgram, qw
Start date: 2012-06-06
End date: 2012-06-20
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-04-18
End date: 2012-04-18
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-11
PEG-Intron
Dosage: 30 microgram,
Start date: 2012-06-27
End date: 2012-06-27
PEG-Intron
Dosage: 75 microgram, qw
Start date: 2012-04-25
End date: 2012-04-25
PEG-Intron
Dosage: 50 microgram, qw
Start date: 2012-05-09
End date: 2012-05-30
PEG-Intron
Dosage: 40 microgram, unk
Start date: 2012-07-04
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-11
End date: 2012-04-14
Telavic
Dosage: 1.5 g, qd
Administration route: Oral
End date: 2012-06-27
Telavic
Dosage: unk
Administration route: Oral
Start date: 2012-04-17
Other drugs received by patient: Glycyron; Talion (Bepotastine Besylate); Loxonin; Loxonin; Urso 250; NEO-Minophagen C; Motilium
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Blood Uric Acid Increased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 30 microgram per kilogram, qw
Start date: 2012-07-05
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-21
PEG-Intron
Dosage: 50 microgram per kilogram, qw
Start date: 2012-07-12
PEG-Intron
Dosage: 70 microgram per kilogram, qw
Start date: 2012-07-19
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-07-05
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-06-27
Other drugs received by patient: Theo-DUR; Lendormin; Mucodyne
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Nausea
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-06-17
Other drugs received by patient: Talion (Bepotastine Besylate); Mucosta; Loxonin
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-04
PEG-Intron
Dosage: 1.5 ?g/kg, qw
Indication: Hepatitis C
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-02-08
Ribavirin
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
End date: 2012-02-07
Other drugs received by patient: Lorfenamin; Livalo; Epadel S; Claritin Reditabs; Sodium Ferrous Citrate
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.8 microgram per kilogram, qw
Start date: 2012-05-08
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-04-24
PEG-Intron
Dosage: 1.0 microgram per kilogram, qw
Start date: 2012-05-01
End date: 2012-05-01
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-18
End date: 2012-07-12
Other drugs received by patient: Claritin; Ferotym; Livalo; Epadel S
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-07
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-25
End date: 2012-07-30
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-06-24
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-07
End date: 2012-07-08
Other drugs received by patient: Loxonin; Olopatadine HCL; Allopurinol; Betamethasone Sodium Phosphate
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Renal Impairment, Anaemia, Platelet Count Decreased, Decreased Appetite
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 mcg /kg/week
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-04-25
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-06-26
PEG-Intron
Dosage: 1.0 mcg /kg/week
Start date: 2012-04-26
End date: 2012-06-06
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-26
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-13
End date: 2012-06-07
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-06-26
End date: 2012-07-24
Other drugs received by patient: Motilium; Lorfenamin; Motilium; L Cartin; Rikkunshi-TO; Epadel
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Psychiatric Symptom
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-16
Rebetol
Dosage: cumulative dose: 20000 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-13
Rebetol
Dosage: cumulative dose: 20000 mg
Administration route: Oral
Start date: 2012-03-13
End date: 2012-03-16
Telavic
Dosage: cumulative dose: 56250 mg
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-21
End date: 2012-03-16
Other drugs received by patient: Loxoprofen; Allopurinol
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Renal Impairment, Anaemia, Pancreatitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-04-27
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-24
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-25
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-27
End date: 2012-05-17
Other drugs received by patient: Antebate; Prednisolone; Dexaltin; Ubiron; Aspara CA; Loxonin; Onealfa; Diovan; Berizym (Lysozyme Chloride); Mirobect; Amlodipine; Isoleucine (+) Leucine (+) Valine; Lansoprazole; Mucosta
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-27
Patient:
Reactions: Anaemia, Rash, Haemolytic Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-24
End date: 2012-05-21
Ribavirin
Dosage: 500 mg, qd
Administration route: Oral
Start date: 2012-05-22
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-03-21
End date: 2012-04-03
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-02-27
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-28
End date: 2012-03-17
Ribavirin
Dosage: 300 mg, qd
Administration route: Oral
Start date: 2012-04-04
End date: 2012-04-23
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-01-31
End date: 2012-03-16
Other drugs received by patient: Coniel; Famotidine; Allopurinol; Celestamine (Betamethasone (+) Dexchlorpheniramine Maleate (+) Fluphen; Isosorbide Dinitrate
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-27
Patient:
Reactions: Malaise
Drug(s) suspected as cause:
PEG-Intron
Dosage: 100 microgram per kilogram, unk
Indication: Hepatitis C
Start date: 2012-06-15
End date: 2012-07-13
Rebetol
Dosage: 800 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-15
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-07-06
End date: 2012-07-13
Other drugs received by patient: Diflunisal; Januvia; Basen
Possible PEG-Intron side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-27
Patient:
Reactions: White Blood Cell Count Decreased, Contusion, Anaemia, Fall, Loss of Consciousness, Haemoglobin Decreased, Anxiety, Dysgeusia, Urine Uric Acid Increased, Disturbance in Attention, Injury, Feeling Abnormal, Asthenia
Drug(s) suspected as cause:
PEG-Intron
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qam
Indication: Hepatitis C
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Rebetol
Dosage: unk unk, qpm
Start date: 2012-03-03
Rebetol
Dosage: unk unk, qpm
Rebetol
Dosage: unk unk, qam
Victrelis
Dosage: unk unk, unknown
Indication: Hepatitis C
Start date: 2012-03-31
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-25
Patient:
Reactions: Anaemia, Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-12
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-07-02
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
End date: 2012-07-01
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-12
Other drugs received by patient: Claritin Reditabs Tablets 10 MG; Diltiazem Hydrochloride; Livalo; Epadel S; Ferotym
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from United States on 2012-08-25
Patient:
Reactions: Fatigue, RED Blood Cell Count Decreased, NO Therapeutic Response, Insomnia, Dysuria, Constipation
Drug(s) suspected as cause:
PEG-Intron
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-25
Patient:
Reactions: Blood Creatinine Increased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.43 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-17
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-17
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-07-13
End date: 2012-07-15
Telavic
Dosage: 750 mg, qd
Administration route: Oral
Start date: 2012-07-16
End date: 2012-07-17
Other drugs received by patient: Candesartan Cilexetil; Ursodiol; Januvia; Miglitol; Glimepiride; Glimepiride; Zetia
Possible PEG-Intron side effects in
Reported by a pharmacist from Japan on 2012-08-25
Patient:
Reactions: Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 0.75 microgram per kilogram, unk
Start date: 2012-07-16
PEG-Intron
Dosage: 1.5mcg/kg
Start date: 2012-07-09
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Start date: 2012-07-09
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Start date: 2012-07-09
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-07-13
Possible PEG-Intron side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-08-24
Patient: 54 year old female
Reactions: Anxiety Disorder, Nausea, Insomnia, Decreased Appetite
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Indication: Hepatitis C
Start date: 2012-02-15
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-28
Ribavirin
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-02-29
End date: 2012-06-12
Ribavirin
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-13
End date: 2012-06-19
Ribavirin
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-06-20
End date: 2012-07-31
VX-950
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-02-15
End date: 2012-02-21
VX-950
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-02-22
End date: 2012-05-08
Other drugs received by patient: Ursodiol; Loxonin; Loxonin; Omeprazole; Januvia; Loxonin
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Haemoglobin Decreased, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-11
Rebetol
Dosage: unk
Rebetol
Dosage: 200 mg, unk
Administration route: Oral
Start date: 2012-06-25
End date: 2012-07-16
Rebetol
Dosage: 400 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-11
End date: 2012-06-24
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-11
End date: 2012-06-15
Telavic
Dosage: 1500 mg, unk
Administration route: Oral
Start date: 2012-06-16
End date: 2012-07-02
Telavic
Dosage: 1000 unk, unk
Administration route: Oral
Start date: 2012-07-03
End date: 2012-07-09
Other drugs received by patient: Valsartan and Hydrochlorothiazide
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-24
Patient:
Reactions: Rash
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-19
End date: 2012-07-30
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-19
End date: 2012-07-30
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-19
End date: 2012-07-30
Possible PEG-Intron side effects in
Reported by a consumer/non-health professional from Japan on 2012-08-24
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 80 microgram, qw
Indication: Hepatitis C
Start date: 2008-02-07
End date: 2008-06-02
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2008-02-07
End date: 2008-02-28
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2008-02-29
End date: 2008-03-06
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2008-03-07
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Stevens-Johnson Syndrome
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Antiviral (Unspecified)
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-05-14
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-05-14
PEG-Intron
Dosage: dosage is uncertain during a day.
Start date: 2012-05-24
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-04-29
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-04-30
Rebetol
Dosage: dosage is uncertain during a day.
Administration route: Oral
Start date: 2012-05-24
Rebetol
Dosage: 200 mg, qd
Administration route: Oral
Start date: 2012-05-08
End date: 2012-05-14
Telavic
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-03-19
End date: 2012-05-14
Other drugs received by patient: Diovan; Nizatidine; Nizatidine; Loxonin; Diovan; Primperan TAB; Diclofenac Sodium; Allopurinol; Urso 250; Norvasc; Urso 250; Norvasc
Possible PEG-Intron side effects in female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-24
Patient: female
Reactions: Back Pain, Oedema Peripheral, Headache
Drug(s) suspected as cause:
PEG-Intron
Dosage: dosage form: unspecified
Indication: Hepatitis C
Start date: 2012-05-01
Ribavirin
Dosage: dosage form: unspecified
Indication: Hepatitis C
Start date: 2012-05-01
VX-950
Dosage: 750 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-01
End date: 2012-07-22
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Renal Impairment, Blood Creatinine Increased
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-05-28
End date: 2012-06-04
Rebetol
Dosage: 1000 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-28
End date: 2012-06-01
Telavic
Dosage: 2250 mg, unk
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient: Urso 250
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Renal Disorder, Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-28
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-28
End date: 2012-05-10
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-05-11
End date: 2012-05-31
Rebetol
Dosage: 200 mg, qd
Start date: 2012-06-01
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-28
End date: 2012-05-03
Telavic
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2012-06-01
End date: 2012-06-21
Telavic
Dosage: 1500 mg, qd
Start date: 2012-06-22
End date: 2012-07-20
Telavic
Dosage: 1500 mg, qd
Administration route: Oral
Start date: 2012-05-04
End date: 2012-05-31
Other drugs received by patient: Ferotym; Livalo; Epadel S; Claritin Reditabs
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Anaemia
Drug(s) suspected as cause:
PEG-Intron
Dosage: 1.5 microgram per kilogram, qw
Indication: Hepatitis C
Start date: 2012-06-06
Rebetol
Dosage: 400 mg, qd
Administration route: Oral
Start date: 2012-06-20
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
End date: 2012-06-19
Telavic
Dosage: 1500 milligrams, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-06
Other drugs received by patient: Lexotan; Norvasc; Mucosta; Epadel S; Ferotym; Depas; Maglax (Magnesium Oxide); Claritin Reditabs Tablets 10 MG; Livalo
Possible PEG-Intron side effects in
Reported by a physician from Japan on 2012-08-24
Patient:
Reactions: Renal Impairment, Vomiting, Nausea, Dizziness, General Physical Health Deterioration
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Glycyron
Dosage: 6 df, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-06-14
End date: 2012-07-04
PEG-Intron
Dosage: 1.5mcg/kg/week
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Rebetol
Dosage: 800 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-12
Rebetol
Dosage: 600 mg, qd
Administration route: Oral
Start date: 2012-04-13
End date: 2012-04-16
Telavic
Dosage: 2250 mg, qd
Administration route: Oral
Indication: Hepatitis C
Start date: 2012-04-10
End date: 2012-04-16
Other drugs received by patient: Adalat CC; Olmesartan Medoxomil; Olmesartan Medoxomil; Loxonin; Loxonin; Adalat CC; Adalat CC; Glycyron; Doxazosin Mesylate; Metformin HCL; Kinedak; Adalat CC; Nesina; Loxonin; Potassium Chloride; Trichlormethiazide; Amaryl; Lendormin; Allopurinol; Trichlormethiazide; Vitamin E; Primperan TAB; Amaryl; Loxonin; Metformin HCL; Kinedak; Rohypnol; Doxazosin Mesylate; Nesina; Urso 250; Vitamin B12; Electrolytes (Unspecified) (+) Sodium Lactate; Lyrica; Lendormin D
Page 1 Next >>
|
